If Tenet Healthcare sat on your watchlist instead of in your account, the recent share move may feel like a missed call. Holding Tenet Healthcare from the start of the year would have returned 43.6%, including dividends. That outcome arrived after big earnings beats and higher guidance, yet the key question is simpler. If the opportunity hinged on Tenet’s bet that aging patients would keep shifting complex procedures to its outpatient network, how visible was that assumption back on 1 January...
Hospital leader Tenet stock hits new highs Thursday with solid gains after gapping above its latest buy point.
Detailed price information for Moderna Inc (MRNA-Q) from The Globe and Mail including charting and trades.
Detailed price information for Tenet Healthcare Corp (THC-N) from The Globe and Mail including charting and trades.
Tenet Healthcare reported third quarter 2026 sales of US$5.63b and net income of US$1.0b, alongside nine month net income of US$2.53b, and raised full year guidance for revenue, earnings and diluted EPS. Management credited higher acuity procedures in United Surgical Partners International, tighter hospital cost control and significant free cash flow used for debt refinancing and share repurchases as key drivers of the stronger outlook. The focus now turns to how Tenet Healthcare's upgraded...
Tenet Healthcare Corp (THC) posted 80% adjusted EPS growth to $6.64 and lifted full-year EBITDA guidance by $195 million, even as it braces for a $450 million Conifer transition headwind in 2027.
Detailed price information for Tenet Healthcare Corp (THC-N) from The Globe and Mail including charting and trades.
Recently, Zacks.com users have been paying close attention to Tenet (THC). This makes it worthwhile to examine what the stock has in store.
Medicaid cuts might be softened if Democrats win, analysts say.
Tenet Healthcare (NYSE:THC) has outperformed the market over the past 15 years by 6.23% on an annualized basis producing an average annual return of 19.49%. Currently, Tenet Healthcare has a market capitalization of
Tenet Healthcare (THC) reached $258.62 at the closing of the latest trading day, reflecting a +1.83% change compared to its last close.
Tenet Healthcare currently trades at $255.62 and has been a dream stock for shareholders. It’s returned 271% since October 2021, blowing past the S&P 500’s 76% gain. The company has also beaten the index over the past six months as its stock price is up 34.3% thanks to its solid quarterly results.
Detailed price information for Tenet Healthcare Corp (THC-N) from The Globe and Mail including charting and trades.
Tenet Healthcare (NYSE:THC) has outperformed the market over the past 10 years by 14.65% on an annualized basis producing an average annual return of 28.19%. Currently, Tenet Healthcare has a market capitalization of
Here is how Tenet Healthcare (THC) and Adicet Bio, Inc. (ACET) have performed compared to their sector so far this year.
Tenet Healthcare Corporation (NYSE:THC) is increasingly relying on its ambulatory business as an important driver of growth, combining favorable long-term outpatient trends with attractive margins. According to BMO Capital Markets, Tenet’s ambulatory operations give the company exposure to an end market with favorable long-term growth characteristics. The firm expects continued investment in Tenet’s hospital operations […]
This is the newest page. Registered accounts read further back.